U.S. Airlines Stock News

Event driven snapshot of Advance Auto Parts stock Recent trading in Advance Auto Parts (AAP) has caught investor attention after the stock fell 5.1% in the latest session, extending a decline of about 17% over the past month. See our latest analysis for Advance Auto Parts. The recent 1 day share price drop of 5.11% and 7 day decline of 15.99% sit against a year to date share price gain of 21.29% and a 1 year total shareholder return of 37.31%. Together, these figures suggest shorter term...

DHT Holdings, Inc. reported past first-quarter 2026 results with revenue rising to US$186.48 million and net income to US$164.53 million, lifting basic and diluted EPS from continuing operations to US$1.02 year on year. Management attributed the stronger earnings to robust spot market performance and ongoing fleet renewal, while signaling caution on further expansion despite a supportive balance sheet and a still-firm freight market backdrop. We’ll now examine how this stronger-than-expected...

Recently, LyondellBasell Industries reported a marked improvement in analyst sentiment, with earnings estimates upgraded and its Zacks rating raised to Strong Buy, reflecting greater confidence in its earnings outlook. At the same time, valuation tools such as GuruFocus flag the shares as trading above intrinsic value while insiders have sold around US$26.3 million of stock in three months, highlighting a tension between bullish analyst views and insider caution. Next, we’ll explore how this...

Voya Financial, Inc. has already reported first-quarter 2026 results, with revenue rising to US$2,031 million and net income to US$182 million, while also announcing June 2026 distribution payments for several Voya Investment Management closed-end funds. Despite higher earnings per share from continuing operations and positive commentary around capital-light operations and resilient business lines, investors are weighing these strengths against an operating income shortfall and new managed...

Erasca (ERAS) is under pressure after disclosing that Revolution Medicines accused its lead candidate ERAS-0015 of patent infringement and trade secret misappropriation, prompting multiple securities law investigations and raising fresh questions about the program’s long term prospects. See our latest analysis for Erasca. The latest legal headlines arrive after a sharp 43.79% decline in the 30 day share price return. This follows a strong year to date share price return of 184.96% and a very...

There's been a notable change in appetite for Paysafe Limited ( NYSE:PSFE ) shares in the week since its first-quarter...

In early May 2026, Flywire Corporation reported first-quarter 2026 sales of US$188.11 million, a shift to net income of US$12.52 million, and issued guidance for FX-neutral revenue less ancillary services growth of 18%–24% for both the second quarter and full year. The company coupled this profit pivot with continued global client wins, including Penn State for tuition payments, and an aggressive share repurchase program that has already retired more than 7% of its stock while eliminating...

In recent days, Deutsche Bank highlighted that value-seeking shoppers are lifting expectations for Burlington Stores’ first-quarter same-store sales growth to about 7–8%, while Burlington also prepared to report its past first-quarter fiscal 2026 results and host an earnings call on May 28. Additionally, Capital International Investors disclosed a passive 10% ownership stake in Burlington, signaling fresh institutional interest in the off-price retailer. This cluster of analyst commentary,...

MasTec (MTZ) is back on investors’ radar after its latest first quarter update, which paired 34% year over year revenue growth with a record backlog and a higher full year 2026 revenue and adjusted EBITDA outlook. See our latest analysis for MasTec. That operational update has arrived alongside a powerful rebound in the stock, with the 90 day share price return of 53.93% and 1 year total shareholder return of 162.98% pointing to strong momentum after earlier volatility. If MasTec’s run has...

Earlier this month, Yelp Inc. reported first-quarter 2026 results showing net revenue of US$361.46 million, lower net income of US$17.74 million versus a year ago, and reaffirmed its full-year 2026 net revenue outlook of US$1.455 billion to US$1.475 billion. Over the same period, Yelp continued its long-running capital return program by repurchasing 5,087,000 shares for US$125.04 million, bringing total buybacks under its 2018 authorization to 51,710,000 shares at a cumulative cost of...

C3.ai (AI) stock recently sold off alongside the broader tech sector after a hotter than expected Consumer Price Index report reduced expectations for Federal Reserve rate cuts and pushed yields higher. See our latest analysis for C3.ai. Those macro jitters have hit C3.ai on top of company specific news, with leadership changes, cost cuts and guidance revisions all landing during a period when the 1 day share price return fell 4.21% and the year to date share price return is down 37.09%...

ArcBest recently gained shareholder approval to move its legal incorporation from Delaware to Texas, a change that will not alter its headquarters, operations, management, or workforce. This shift toward Texas law, which the board views as offering clearer and more predictable protections for directors and officers, comes as the company faces underwhelming unit sales, declining profitability, and a forward P/E ratio of 21.2x. Next, we’ll examine how ArcBest’s move to Texas incorporation,...

Recent performance context Knight-Swift Transportation Holdings (KNX) has attracted attention after a recent move in its stock price, with investors weighing the company’s current fundamentals alongside its record of historical total returns. See our latest analysis for Knight-Swift Transportation Holdings. The recent 1-day share price return of 1.51% builds on a 7-day move of 7.82% and a 90-day share price return of 15.97%. The 1-year total shareholder return of 53.56% and 5-year total...

Earlier in Q2 2026, Welltower reported strong Q1 results, with revenue rising about 40%, senior housing same-store NOI up sharply, and portfolio occupancy improving to roughly 89%, prompting management to raise full-year 2026 normalized FFO guidance while keeping its payout ratio under 50%. This combination of faster growth and a conservative payout suggests management sees room to support dividends while continuing to invest across its healthcare real estate platform. We’ll now explore how...

First quarter earnings shift draws fresh attention to Protagonist Therapeutics Protagonist Therapeutics (PTGX) has moved from a loss to a profit in the first quarter of 2026, reporting net income of US$3.78 million after a net loss of US$11.66 million a year earlier. See our latest analysis for Protagonist Therapeutics. The earnings swing to profit comes after a strong run for investors, with the share price delivering a 25.39% return over the past 90 days and a very large 292.25% total...

Oracle (ORCL) is back in focus after a series of AI and cloud announcements, including defense contracts for classified environments, strong Q3 FY2026 revenue and backlog figures, and fresh customer wins with Ishan Technologies and Samsung. See our latest analysis for Oracle. Those AI and cloud headlines are arriving after a sharp run, with Oracle’s share price gaining 13.63% over the past month and 20.49% over 90 days, while its 1-year total shareholder return of 21.43% and 5-year total...

Klaviyo’s latest catalysts Klaviyo (KVYO) is back in focus after a packed early May, combining first quarter 2026 results, higher full year revenue guidance, an expanded integration with Anthropic’s Claude, and a new US$500 million share repurchase authorization. See our latest analysis for Klaviyo. Despite a packed early May that included stronger first quarter 2026 results, raised full year revenue guidance, an expanded Anthropic integration and a new repurchase plan, Klaviyo’s share price...

In early May 2026, BioCryst Pharmaceuticals reported first-quarter revenue of US$156.41 million but a net loss of US$721.81 million, while maintaining full-year 2026 revenue guidance of US$635 million to US$660 million and announcing a European licensing deal for navenibart that includes a US$70 million upfront payment plus potential milestones and royalties. The navenibart agreement with Neopharmed Gentili’s Irish affiliate both brings immediate capital to BioCryst and outsources European...

Biogen (NasdaqGS:BIIB) is advancing its experimental Alzheimer’s drug diranersen into late stage trials after Phase 2 CELIA data. The therapy, an antisense oligonucleotide that targets tau protein, did not meet the study’s primary endpoint but showed strong biomarker changes and signs of cognitive benefit. The decision extends Biogen’s Alzheimer’s efforts beyond amyloid focused treatments and increases attention on its neurology pipeline. For you as an investor, this keeps Biogen in the...

Magnolia Oil & Gas Corporation ( NYSE:MGY ) shareholders will have a reason to smile today, with the analysts making...

Shareholders might have noticed that Prelude Therapeutics Incorporated ( NASDAQ:PRLD ) filed its first-quarter result...

Today is shaping up negative for LENZ Therapeutics, Inc. ( NASDAQ:LENZ ) shareholders, with the analysts delivering a...

The latest analyst coverage could presage a bad day for Arcus Biosciences, Inc. ( NYSE:RCUS ), with the analysts making...

Why International Flavors & Fragrances Stock Is Back on Investors’ Radar International Flavors & Fragrances (IFF) has drawn fresh attention after recent trading, with the share price at about $73.10 and mixed return patterns across the past week, month and past 3 months. See our latest analysis for International Flavors & Fragrances. Recent trading has been choppy, with the share price down about 4% on the day and about 10% across the past week. It is still showing a 7% year to date share...